Faricimab Reverts VEGF-A165-Induced Impairment of the Barrier Formed by Retinal Endothelial CellsDominik M. Jung(Justus-Liebig-Universität Gießen), Heidrun L. Deissler(Universität Ulm)International Journal of Molecular SciencesMay 1, 202510.3390/ijms26094318Cited by 1SaveCiteExport RISWatch citationsRelated PapersImpairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A165 No Longer Depends on the Growth Factor’s Presence|Biomolecules|2022|5